Articles publiés

Abuse and misuse of second-generation antipsychotics: an analysis using VigiBase TM , the World Health Organisation pharmacovigilance database

Roy S, Charreteur R, Peries M, Kheloufi F, Eiden C, Nagot N, Donnadieu-Rigole H, Micallef J, Peyrière H. Abuse and misuse of second-generation antipsychotics: an analysis using VigiBase TM , the World Health Organisation pharmacovigilance database. Br J Clin Pharmacol. 2022 May 27. doi: 10.1111/bcp.15420. Epub ahead of print. PMID: 35633029.  

Augmentation de l’abus de méthylphénidate : repérage et profils sur 13 années

Guerra C, Soeiro T, Lacroix C, Jouve E, Micallef J, Frauger E. Augmentation de l’abus de méthylphénidate : repérage et profils sur 13 années [Increasing methylphenidate abuse: Tracking and profiles during 13-years]. Therapie. 2022 Apr 26:S0040-5957(22)00066-X. French. doi: 10.1016/j.therap.2022.03.006. Epub ahead of print. PMID: 35599193.

Perception of the Regulatory Change for Zolpidem Prescription by French General Practitioners and Its Relation to Prescription Behavior

Laforgue EJ, Istvan M, Schreck B, Mainguy M, Jolliet P, Grall-Bronnec M, Victorri-Vigneau C. Perception of the Regulatory Change for Zolpidem Prescription by French General Practitioners and Its Relation to Prescription Behavior. J Clin Med. 2022 Apr 13;11(8):2176. doi: 10.3390/jcm11082176. PMID: 35456269; PMCID: PMC9032177.

Retour haut de page